{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:17:54Z","timestamp":1761862674128,"version":"3.33.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1007\/s11938-004-0033-1","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T19:28:06Z","timestamp":1180898886000},"page":"121-131","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of functional dyspepsia"],"prefix":"10.1007","volume":"7","author":[{"given":"Silvia","family":"Delgado-Aros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Cremonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"suppl 2","key":"33_CR1","first-page":"37","volume":"45","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Stanghellini V, Heading RC, et al.: Functional gastroduodenal disorders. Gut 1999, 45(suppl 2):37\u201342.","journal-title":"Gut"},{"key":"33_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365529409105352","volume":"29","author":"L Kay","year":"1994","unstructured":"Kay L, Jorgensen T: Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994, 29:2\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"33_CR3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1023\/A:1005468332122","volume":"45","author":"L Frank","year":"2000","unstructured":"Frank L, Kleinman L, Ganoczy D, et al.: Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci 2000, 45:809\u2013818.","journal-title":"Dig Dis Sci"},{"key":"33_CR4","first-page":"37","volume":"3","author":"DW Marsland","year":"1976","unstructured":"Marsland DW, Wood M, Mayo F: Content of family practice. Part I. Rank order of diagnoses by frequency. Part II. Diagnoses by disease category and age\/sex distribution. J Fam Pract 1976, 3:37\u201368.","journal-title":"J Fam Pract"},{"issue":"suppl","key":"33_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00365528509103934","volume":"109","author":"O Nyren","year":"1985","unstructured":"Nyren O, Adami HO, Gustavsson S, et al.: Social and economic effects of non-ulcer dyspepsia. Scand J Gastroenterol 1985, 109(suppl):41\u201347.","journal-title":"Scand J Gastroenterol"},{"key":"33_CR6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0016-5085(98)70542-6","volume":"114","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Silverstein MD, Agreus L, et al.: AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998, 114:582\u2013595.","journal-title":"Gastroenterology"},{"issue":"suppl 12","key":"33_CR7","first-page":"S3","volume":"162","author":"SJ Veldhuyzen van Zanten","year":"2000","unstructured":"Veldhuyzen van Zanten SJ, Flook N, Chiba N, et al.: An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. Can Med Assoc J 2000, 162(suppl 12):S3-S23.","journal-title":"Can Med Assoc J"},{"key":"33_CR8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0140-6736(90)91301-P","volume":"335","author":"EA Rauws","year":"1990","unstructured":"Rauws EA, Tytgat GN: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990, 335:1233\u20131235.","journal-title":"Lancet"},{"key":"33_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-134-5-200103060-00008","volume":"134","author":"L Laine","year":"2001","unstructured":"Laine L, Schoenfeld P, Fennerty MB: Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 134:361\u2013369.","journal-title":"Ann Intern Med"},{"key":"33_CR10","first-page":"CD002096","volume":"1","author":"P Moayyedi","year":"2003","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2003, 1:CD002096. Well performed meta-analysis. The authors have made a great effort to recompile the best evidence and conclude that eradication of Helicobacter pylori is modestly efficacious in functional dyspepsia","journal-title":"Cochrane Database Syst Rev"},{"key":"33_CR11","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1111\/j.1572-0241.2003.08724.x","volume":"98","author":"P Moayyedi","year":"2003","unstructured":"Moayyedi P, Deeks J, Talley N, et al.: An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003, 98:2621\u20132626.","journal-title":"Am J Gastroenterol"},{"key":"33_CR12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.321.7262.659","volume":"321","author":"P Moayyedi","year":"2000","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000, 321:659\u2013664. A useful cost-effectiveness model is presented here","journal-title":"BMJ"},{"key":"33_CR13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJM198602063140603","volume":"314","author":"O Nyren","year":"1986","unstructured":"Nyren O, Adami HO, Bates S, et al.: Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986, 314:339\u2013343.","journal-title":"N Engl J Med"},{"key":"33_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/00365528809093840","volume":"23","author":"R Gotthard","year":"1988","unstructured":"Gotthard R, Bodemar G, Brodin U, et al.: Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988, 23:7\u201318.","journal-title":"Scand J Gastroenterol"},{"key":"33_CR15","first-page":"CD001960","volume":"1","author":"P Moayyedi","year":"2003","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Pharmacological interventions for non-ulcer dyspepsia. CochraneDatabase Syst Rev 2003, 1:CD001960. Well performed meta-analysis.","journal-title":"CochraneDatabase Syst Rev"},{"key":"33_CR16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/003655202762671260","volume":"37","author":"E Bolling-Sternevald","year":"2002","unstructured":"Bolling-Sternevald E, Lauritsen K, Aalykke C, et al.: Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 2002, 37:1395\u20131402.","journal-title":"Scand J Gastroenterol"},{"key":"33_CR17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9270(00)02314-5","volume":"96","author":"SJ Veldhuyzen van Zanten","year":"2001","unstructured":"Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, et al.: Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001, 96:689\u2013696.","journal-title":"Am J Gastroenterol"},{"key":"33_CR18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/gut.51.5.701","volume":"51","author":"LA Houghton","year":"2002","unstructured":"Houghton LA, Calvert EL, Jackson NA, et al.: Visceral sensation and emotion: a study using hypnosis. Gut 2002, 51:701\u2013704.","journal-title":"Gut"},{"issue":"suppl 11","key":"33_CR19","first-page":"7","volume":"97","author":"LJ Brandt","year":"2002","unstructured":"Brandt LJ, Bjorkman D, Fennerty MB, et al.: Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002, 97(suppl 11):7\u201326.","journal-title":"Am J Gastroenterol"},{"key":"33_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/gast.2003.50055","volume":"124","author":"F Creed","year":"2003","unstructured":"Creed F, Fernandes L, Guthrie E, et al.: The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003, 124:303\u2013317.","journal-title":"Gastroenterology"},{"key":"33_CR21","first-page":"CD002301","volume":"4","author":"S Soo","year":"2001","unstructured":"Soo S, Moayyedi P, Deeks J, et al.: Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2001, 4:CD002301.","journal-title":"Cochrane Database Syst Rev"},{"key":"33_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/16506078809456271","volume":"17","author":"S Bates","year":"1988","unstructured":"Bates S, Sjoden PO, Nyren O: Behavioral treatment of non-ulcer dyspepsia. Scand J Behav Ther 1988, 17:155\u2013165.","journal-title":"Scand J Behav Ther"},{"key":"33_CR23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","volume":"119","author":"J Hamilton","year":"2000","unstructured":"Hamilton J, Guthrie E, Creed F, et al.: A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000, 119:661\u2013669. A well-done study where efforts were made to overcome the technical difficulties of performing randomized and double-blind studies applying psychologic interventions. Provides evidence of a potential role of psychotherapy in functional dyspepsia, but the subgroup analyses performed may have been biased.","journal-title":"Gastroenterology"},{"key":"33_CR24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0022-3999(94)90026-4","volume":"38","author":"TT Haug","year":"1994","unstructured":"Haug TT, Wilhelmsen I, Svebak S, et al.: Psychotherapy in functional dyspepsia. J Psychosom Res 1994, 38:735\u2013744.","journal-title":"J Psychosom Res"},{"key":"33_CR25","doi-asserted-by":"crossref","unstructured":"Management of dyspepsia: report of a working party. Lancet 1988, 1:576\u2013579.","DOI":"10.1016\/S0140-6736(88)91364-5"},{"key":"33_CR26","first-page":"145","volume":"4","author":"NJ Talley","year":"1991","unstructured":"Talley NJ, Colin-Jones DG, Koch KL, et al.: Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991, 4:145\u2013160.","journal-title":"Gastroenterol Int"},{"key":"33_CR27","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.37071","volume":"123","author":"EL Calvert","year":"2002","unstructured":"Calvert EL, Houghton LA, Cooper P, et al.: Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002, 123:1778\u20131785. An excellent study showing that functional dyspepsia may benefit from hypnotherapy","journal-title":"Gastroenterology"},{"key":"33_CR28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","volume":"108","author":"JL Jackson","year":"2000","unstructured":"Jackson JL, O\u2019Malley PG, Tomkins G, et al.: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000, 108:65\u201372.","journal-title":"Am J Med"},{"key":"33_CR29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1152\/ajpgi.00266.2002","volume":"284","author":"HJ Chial","year":"2003","unstructured":"Chial HJ, Camilleri M, Burton D, et al.: Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol 2003, 284:130\u2013137.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"33_CR30","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1046\/j.1365-2036.2002.01339.x","volume":"16","author":"J Thompson Coon","year":"2002","unstructured":"Thompson Coon J, Ernst E: Systematic review: herbal medicinal products for non-ulcer dyspepsia. Aliment Pharmacol Ther 2002, 16:1689\u20131699.","journal-title":"Aliment Pharmacol Ther"},{"key":"33_CR31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0016-5085(91)90459-X","volume":"101","author":"JM Hills","year":"1991","unstructured":"Hills JM, Aaronson PI: The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. Gastroenterology 1991, 101:55\u201365.","journal-title":"Gastroenterology"},{"key":"33_CR32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0006-8993(94)91247-5","volume":"637","author":"DM Saucier","year":"1994","unstructured":"Saucier DM, Kavaliers M: Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiateinduced analgesia in male deer mice. Brain Res 1994, 637:292\u2013296.","journal-title":"Brain Res"},{"key":"33_CR33","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1046\/j.1365-2036.2002.01358.x","volume":"16","author":"SD Kuiken","year":"2002","unstructured":"Kuiken SD, Lei A, Tytgat GN, et al.: Effect of the lowaffinity, noncompetitive N-methyl-d-aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers. Aliment Pharmacol Ther 2002, 16:1955\u20131962.","journal-title":"Aliment Pharmacol Ther"},{"key":"33_CR34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/PL00000720","volume":"57","author":"PT Schmidt","year":"2000","unstructured":"Schmidt PT, Holst JJ: Tachykinins in regulation of gastric motility and secretion. Cell Mol Life Sci 2000, 57:579\u2013588.","journal-title":"Cell Mol Life Sci"},{"key":"33_CR35","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1111\/j.1572-0241.2000.03177.x","volume":"95","author":"DY Kim","year":"2000","unstructured":"Kim DY, Camilleri M: Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000, 95:2698\u20132709.","journal-title":"Am J Gastroenterol"},{"key":"33_CR36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1476-5381.1995.tb13263.x","volume":"114","author":"SE Banner","year":"1995","unstructured":"Banner SE, Sanger GJ: Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity. Br J Pharmacol 1995, 114:558\u2013562.","journal-title":"Br J Pharmacol"},{"key":"33_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2982.2003.00389.x","volume":"15","author":"F Cremonini","year":"2003","unstructured":"Cremonini F, Delgado-Aros S, Camilleri M: Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 2003, 15:79\u201386.","journal-title":"Neurogastroenterol Motil"},{"key":"33_CR38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","volume":"15","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Van Zanten SV, Saez LR, et al.: A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001, 15:525\u2013537.","journal-title":"Aliment Pharmacol Ther"},{"key":"33_CR39","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","volume":"17","author":"F Simonin","year":"1998","unstructured":"Simonin F, Valverde O, Smadja C, et al.: Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. Embo J 1998, 17:886\u2013897.","journal-title":"Embo J"},{"key":"33_CR40","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/BF02209014","volume":"40","author":"M Dapoigny","year":"1995","unstructured":"Dapoigny M, Abitbol JL, Fraitag B: Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study. Dig Dis Sci 1995, 40:2244\u20132249.","journal-title":"Dig Dis Sci"},{"key":"33_CR41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5085(99)70226-X","volume":"116","author":"M Delvaux","year":"1999","unstructured":"Delvaux M, Louvel D, Lagier E, et al.: The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. Gastroenterology 1999, 116:38\u201345.","journal-title":"Gastroenterology"},{"key":"33_CR42","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.41.5.664","volume":"41","author":"NW Read","year":"1997","unstructured":"Read NW, Abitbol JL, Bardhan KD, et al.: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41:664\u2013668.","journal-title":"Gut"},{"key":"33_CR43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/chir.530060814","volume":"6","author":"R Gottschlich","year":"1994","unstructured":"Gottschlich R, Krug M, Barber A, et al.: kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753. Chirality 1994, 6:685\u2013689.","journal-title":"Chirality"},{"key":"33_CR44","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1476-5381.1994.tb17142.x","volume":"113","author":"A Barber","year":"1994","unstructured":"Barber A, Bartoszyk GD, Bender HM, et al.: A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br J Pharmacol 1994, 113:1317\u20131327.","journal-title":"Br J Pharmacol"},{"key":"33_CR45","first-page":"76","volume":"36","author":"HM Bender","year":"1998","unstructured":"Bender HM, Dasenbrock J: Brain concentrations of asimadoline in mice: the influence of coadministration of various P-glycoprotein substrates. Int J Clin Pharmacol Ther 1998, 36:76\u201379.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"33_CR46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3565(24)37421-X","volume":"285","author":"MB Burton","year":"1998","unstructured":"Burton MB, Gebhart GF: Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. J Pharmacol Exp Ther 1998, 285:707\u2013715.","journal-title":"J Pharmacol Exp Ther"},{"key":"33_CR47","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1152\/jn.2000.83.4.2209","volume":"83","author":"N Ozaki","year":"2000","unstructured":"Ozaki N, Sengupta JN, Gebhart GF: Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat. J Neurophysiol 2000, 83:2209\u20132216.","journal-title":"J Neurophysiol"},{"key":"33_CR48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3959(98)00175-4","volume":"79","author":"JN Sengupta","year":"1999","unstructured":"Sengupta JN, Snider A, Su X, et al.: Effects of kappa opioids in the inflamed rat colon. Pain 1999, 79:175\u2013185.","journal-title":"Pain"},{"key":"33_CR49","first-page":"558","volume":"284","author":"S Delgado-Aros","year":"2003","unstructured":"Delgado-Aros S, Chial HJ, Camilleri M, et al.: Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol 2003, 284:558\u2013566.","journal-title":"Am J Physiol"},{"key":"33_CR50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2036.2003.01670.x","volume":"18","author":"S Delgado-Aros","year":"2003","unstructured":"Delgado-Aros S, Chial HJ, Cremonini F, et al.: Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Aliment Pharmacol Ther 2003, 18:507\u2013514.","journal-title":"Aliment Pharmacol Ther"},{"key":"33_CR51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0091-3057(91)90612-6","volume":"38","author":"GP Smith","year":"1991","unstructured":"Smith GP, Tyrka A, Gibbs J: Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9-to 12-day-old rat pups. Pharmacol Biochem Behav 1991, 38:207\u2013210.","journal-title":"Pharmacol Biochem Behav"},{"key":"33_CR52","doi-asserted-by":"crossref","unstructured":"Castillo EJ, Camilleri M, Burton DD, et al.: Effect of an oral CCK-A agonist, GI181771X, on gastric functions in healthy humans. Gastroenterology 2004, In press.","DOI":"10.1152\/ajpgi.00074.2004"},{"key":"33_CR53","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1053\/gast.1996.v110.pm8613041","volume":"110","author":"C Feinle","year":"1996","unstructured":"Feinle C, D\u2019Amato M, Read NW: Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 1996, 110:1379\u20131385.","journal-title":"Gastroenterology"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-004-0033-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-004-0033-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-004-0033-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T22:02:23Z","timestamp":1737064943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-004-0033-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s11938-004-0033-1","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"type":"print","value":"1092-8472"},{"type":"electronic","value":"1534-309X"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}